Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Christopher Bever Jr

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Multiple Sclerosis

Chemicals & Drugs

Anatomy

Concepts & Ideas

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
12
Li, Qingdi
11
Panitch, Hillel
7
Judge, Susan
7
Dhib-Jalbut, Suhayl
6
Johnson, Kenneth
5
MCFARLAND, HENRY
5
Trisler, David
4
Leslie, James
4
Krebs, Hermano
3
Dipietro, Laura
3
Grattan, Lynn
3
Hogan, Neville
3
Makar, Tapas
3
Whitall, Jill
2
Yeh, Jay

Sign-in to see all Coauthors

Publications

TOP 3
Bever Christopher T; Judge Susan Iv
Sustained-release fampridine for multiple sclerosis.
Finley Margaret A; Dipietro Laura; Ohlhoff Jill; Whitall Jill; Krebs Hermano I; Bever Christopher T
The effect of repeated measurements using an upper extremity robot on healthy adults.
Bever Christopher T
10 questions about 4-aminopyridine and the treatment of multiple sclerosis.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Christopher Bever Jr (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Bever Christopher T; Judge Susan Iv
Sustained-release fampridine for multiple sclerosis.
Expert opinion on investigational drugs 2009;18(7):1013-24.
2009: Finley Margaret A; Dipietro Laura; Ohlhoff Jill; Whitall Jill; Krebs Hermano I; Bever Christopher T
The effect of repeated measurements using an upper extremity robot on healthy adults.
Journal of applied biomechanics 2009;25(2):103-10.
2009: Bever Christopher T
10 questions about 4-aminopyridine and the treatment of multiple sclerosis.
The neurologist 2009;15(3):161-2.
2009: Makar Tapas K; Bever Christopher T; Singh Ishwar S; Royal Walter; Sahu Surasri Nandan; Sura Tushar P; Sultana Shireen; Sura Karna T; Patel Niraj; Dhib-Jalbut Suhayl; Trisler David
Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle.
Journal of neuroimmunology 2009;210(1-2):40-51.
2008: Makar Tapas K; Trisler David; Sura Karna T; Sultana Shireen; Patel Niraj; Bever Christopher T
Brain derived neurotrophic factor treatment reduces inflammation and apoptosis in experimental allergic encephalomyelitis.
Journal of the neurological sciences 2008;270(1-2):70-6.
2008: Makar Tapas K; Trisler David; Bever Christopher T; Goolsby James E; Sura Karna T; Balasubramanian Shailesh; Sultana Shireen; Patel Niraj; Ford David; Singh Ishwar S; Gupta Aditi; Valenzuela Reuben M; Dhib-Jalbut Suhayl
Stem cell based delivery of IFN-beta reduces relapses in experimental autoimmune encephalomyelitis.
Journal of neuroimmunology 2008;196(1-2):67-81.
2008: Bever C T; Holloway R G; Iverson D J; Dubinsky R M; Richardson R M; Sheffield J K; Wang D Z; Franklin G M; Miyasaki J M; Tonn S T; Stevens J C
Invited article: Neurology and quality improvement: an introduction.
Neurology 2008;70(18):1636-40.
2008: Kane Robert L; Bever Christopher T; Ehrmantraut Mary; Forte Alan; Culpepper William J; Wallin Mitchell T
Teleneurology in patients with multiple sclerosis: EDSS ratings derived remotely and from hands-on examination.
Journal of telemedicine and telecare 2008;14(4):190-4.
2007: Judge Susan I V; Smith Paul J; Stewart Peggy E; Bever Christopher T
Potassium channel blockers and openers as CNS neurologic therapeutic agents.
Recent patents on CNS drug discovery 2007;2(3):200-28.
2007: Dipietro L; Krebs H I; Fasoli S E; Volpe B T; Stein J; Bever C; Hogan N
Changing motor synergies in chronic stroke.
Journal of neurophysiology 2007;98(2):757-68.
2007: Halperin J J; Shapiro E D; Logigian E; Belman A L; Dotevall L; Wormser G P; Krupp L; Gronseth G; Bever C T;
Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Neurology 2007;69(1):91-102.
2006: Judge Susan I V; Bever Christopher T
Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment.
Pharmacology & therapeutics 2006;111(1):224-59.
2006: Judge Susan I V; Lee Jennifer M; Bever Christopher T; Hoffman Paul M
Voltage-gated potassium channels in multiple sclerosis: Overview and new implications for treatment of central nervous system inflammation and degeneration.
Journal of rehabilitation research and development 2006;43(1):111-22.
2005: Macclellan Leah R; Bradham Douglas D; Whitall Jill; Volpe Bruce; Wilson P David; Ohlhoff Jill; Meister Christine; Hogan Neville; Krebs Hermano I; Bever Christopher T
Robotic upper-limb neurorehabilitation in chronic stroke patients.
Journal of rehabilitation research and development 2005;42(6):717-22.
2005: Finley Margaret A; Fasoli Susan E; Dipietro Laura; Ohlhoff Jill; Macclellan Leah; Meister Christine; Whitall Jill; Macko Richard; Bever Christopher T; Krebs Hermano I; Hogan Neville
Short-duration robotic therapy in stroke patients with severe upper-limb motor impairment.
Journal of rehabilitation research and development 2005;42(5):683-92.
2005: Graber J; Zhan M; Ford D; Kursch F; Francis G; Bever C; Panitch H; Calabresi P A; Dhib-Jalbut S
Interferon-beta-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis.
Journal of neuroimmunology 2005;161(1-2):169-76.
2005: Sandberg-Wollheim M; Bever C; Carter J; Färkkilä M; Hurwitz B; Lapierre Y; Chang P; Francis G S;
Comparative tolerance of IFN beta-1a regimens in patients with relapsing multiple sclerosis. The EVIDENCE study.
Journal of neurology 2005;252(1):8-13.
2003: Goolsby James; Marty Marie C; Heletz Dafna; Chiappelli Joshua; Tashko Gerti; Yarnell Deborah; Fishman Paul S; Dhib-Jalbut Suhayl; Bever Christopher T; Pessac Bernard; Trisler David
Hematopoietic progenitors express neural genes.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(25):14926-31.
2003: Giovannoni Gavin; Bever Christopher T
Patients with clinically isolated syndromes suggestive of MS: does MRI allow earlier diagnosis?
Neurology 2003;60(1):6-7.
2002: Judge Susan I V; Yeh Jay Z; Goolsby James E; Monteiro Mervyn J; Bever Christopher T
Determinants of 4-aminopyridine sensitivity in a human brain kv1.4 k(+) channel: phenylalanine substitutions in leucine heptad repeat region stabilize channel closed state.
Molecular pharmacology 2002;61(4):913-20.
2001: Li Q Q; Bever C T
Comparison of RANTES chemokine induction by Th1 cytokines in human astroglial cell lines.
International journal of molecular medicine 2001;8(1):95-101.
2001: Schwid S R; Bever C T
The cost of delaying treatment in multiple sclerosis: what is lost is not regained.
Neurology 2001;56(12):1620.
2001: Li Q Q; Burt D R; Bever C T
Glatiramer acetate inhibition of tumor necrosis factor-alpha-induced RANTES expression and release from U-251 MG human astrocytic cells.
Journal of neurochemistry 2001;77(5):1208-17.
2001: Li Q Q; Bever C T; Burt D R; Judge S I; Trisler G D
Induction of RANTES chemokine expression in human astrocytic cells is dependent upon activation of NF-kappaB transcription factor.
International journal of molecular medicine 2001;7(5):527-33.
2001: Li Q Q; Bever C T
Th1 cytokines stimulate RANTES chemokine secretion by human astroglial cells depending on de novo transcription.
Neurochemical research 2001;26(2):125-33.
2001: Li Q Q; Bever C T
Glatiramer acetate blocks interleukin-1-dependent nuclear factor-kappaB activation and RANTES expression in human U-251 MG astroglial cells.
Brain research. Molecular brain research 2001;87(1):48-60.
2001: Li Q Q; Bever C T
Mechanisms underlying the synergistic effect of Th1 cytokines on RANTES chemokine production by human glial cells.
International journal of molecular medicine 2001;7(2):187-95.
1999: Bever C T; Rosenberg G A
Matrix metalloproteinases in multiple sclerosis: targets of therapy or markers of injury?
Neurology 1999;53(7):1380-1.
1999: Judge S I; Monteiro M J; Yeh J Z; Bever C T
Inactivation gating and 4-AP sensitivity in human brain Kv1.4 potassium channel.
Brain research 1999;831(1-2):43-54.
1999: Friend K B; Rabin B M; Groninger L; Deluty R H; Bever C; Grattan L
Language functions in patients with multiple sclerosis.
The Clinical neuropsychologist 1999;13(1):78-94.
1998: Mackowiak P A; Siegel E; Wasserman S S; Cameron E; Nessaiver M S; Bever C T
Effects of IFN-beta on human cerebral blood flow distribution.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1998;18(6):393-7.
1998: Bever C T; Grattan L; Morris J G
Neurologic symptoms following Pfiesteria exposure: case report and literature review.
Maryland medical journal (Baltimore, Md. : 1985) 1998;47(3):120-3.
1998: Li Q; Milo R; Panitch H; Bever C T
Effect of propranolol and IFN-beta on the induction of MHC class II expression and cytokine production by IFN-gamma IN THP-1 human monocytic cells.
Immunopharmacology and immunotoxicology 1998;20(1):39-61.
1998: Li Q; Milo R; Panitch H; Swoveland P; Bever C T
Glatiramer acetate blocks the activation of THP-1 cells by interferon-gamma.
European journal of pharmacology 1998;342(2-3):303-10.
1998: Li Q; Bever C T
Effect of protein kinase modulators on the regulation of cathepsin B activity in THP-1 human monocytic leukemia cells.
Oncology reports 1998;5(1):227-33.
1998: Li Q; Bever C T
Modulation of interferon gamma induced increases in cathepsin B in THP-1 cells by adrenergic agonists and antagonists.
Cell biology international 1998;22(1):13-20.
1997: Li Q; Falkler W A; Bever C T
Endotoxin induces increased intracellular cathepsin B activity in THP-1 cells.
Immunopharmacology and immunotoxicology 1997;19(2):215-37.
1997: Li Q; Bever C T
Interferon-gamma induced increases in intracellular cathepsin B activity in THP-1 cells are dependent on RNA transcription.
Journal of neuroimmunology 1997;74(1-2):77-84.
1996: Bever C T; Anderson P A; Leslie J; Panitch H S; Dhib-Jalbut S; Khan O A; Milo R; Hebel J R; Conway K L; Katz E; Johnson K P
Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial.
Neurology 1996;47(6):1457-62.
1996: Li Q; Bever C T
Gamma interferon induced increases in intracellular cathepsin B activity in PMA primed THP-1 cells are blocked by inhibitors of protein kinase C.
Immunopharmacology and immunotoxicology 1996;18(3):375-96.
1996: Khan O A; Xia Q; Bever C T; Johnson K P; Panitch H S; Dhib-Jalbut S S
Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration.
Neurology 1996;46(6):1639-43.
1995: Bever C T; Grattan L; Panitch H S; Johnson K P
The Brief Repeatable Battery of Neuropsychological Tests for Multiple Sclerosis: a preliminary serial study.
Multiple sclerosis (Houndmills, Basingstoke, England) 1995;1(3):165-9.
1995: Bever C T; Garver D W
Increased cathepsin B activity in multiple sclerosis brain.
Journal of the neurological sciences 1995;131(1):71-3.
1994: Bever C T; Young D; Anderson P A; Krumholz A; Conway K; Leslie J; Eddington N; Plaisance K I; Panitch H S; Dhib-Jalbut S
The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial.
Neurology 1994;44(6):1054-9.
1994: Bever C T; Panitch H S; Johnson K P
Increased cathepsin B activity in peripheral blood mononuclear cells of multiple sclerosis patients.
Neurology 1994;44(4):745-8.
1994: Bever C T
The current status of studies of aminopyridines in patients with multiple sclerosis.
Annals of neurology 1994;36 Suppl():S118-21.
1993: Panitch H S; Bever C T
Clinical trials of interferons in multiple sclerosis. What have we learned?
Journal of neuroimmunology 1993;46(1-2):155-64.
1993: Bever C T
Collaboration and conflict: Ernest E. Hadley and Harry Stack Sullivan, 1930-1945.
The Journal of the American Academy of Psychoanalysis 1993;21(3):387-404.
1992: Bever C T; McFarlin D E; Levy H B
A comparison of interferon responses to poly ICLC in males and females.
Journal of interferon research 1992;Spec No():85-90.
1991: Bever C T; Asofsky R
Augmented IgG anti-acetylcholine receptor response following chronic penicillamine administration.
Journal of neuroimmunology 1991;35(1-3):131-7.
1991: Bever C T; Panitch H S; Levy H B; McFarlin D E; Johnson K P
Gamma-interferon induction in patients with chronic progressive MS.
Neurology 1991;41(7):1124-7.
1991: Bever C T; Jacobson S; Mingioli E S; McFarland H F; McFarlin D E; Levy H B
Changes in leukocyte recirculation, NK cell activity, and HLA-DR expression in peripheral blood mononuclear cells of MS patients treated with Poly ICLC.
International journal of immunopharmacology 1991;13(5):613-8.
1990: Bever C T; Swoveland P
Astrocytosis and cathepsin D activity in experimental measles encephalomyelitis.
Neurochemical research 1990;15(7):667-71.
1990: Bever C T; Leslie J; Camenga D L; Panitch H S; Johnson K P
Preliminary trial of 3,4-diaminopyridine in patients with multiple sclerosis.
Annals of neurology 1990;27(4):421-7.
1989: Leslie J; Bever C T
Analysis of 3,4-diaminopyridine in human serum by solid-phase extraction and high-performance liquid chromatography with ultraviolet detection.
Journal of chromatography 1989;496(1):214-22.
1989: Bever C T; Morgan K D; Whitaker J N
Cathepsin D activity in human peripheral blood mononuclear leukocytes.
Inflammation 1989;13(3):309-16.
1989: Bever C T; Snyder D S; Endres R O; Morgan K D; Postlethwaite A; Whitaker J N
Activation of astrocytic lysosomal proteinases by factors released by mononuclear leukocytes.
Neurochemical research 1989;14(1):37-41.
1988: Bever C T; McFarland H F; McFarlin D E; Levy H B
The kinetics of interferon induction by poly ICLC in humans.
Journal of interferon research 1988;8(4):419-25.
1988: Bever C T; McFarland H F; Levy H B; McFarlin D E
Cortisol induction by poly ICLC: implications for clinical trials of interferon.
Annals of neurology 1988;23(2):196-9.
1986: Bever C T; Salazar A M; Neely E; Ferraraccio B E; Rose J W; McFarland H F; Levy H B; McFarlin D E
Preliminary trial of poly ICLC in chronic progressive multiple sclerosis.
Neurology 1986;36(4):494-8.
1985: Hess W A; Bever C T; McFarlin D E
Liver enzyme abnormalities after poly ICLC infusions.
Cancer treatment reports 1985;69(11):1342.
1985: McFarlin D E; Bever C T; Salazar A M; Levy H B
A preliminary trial of poly(I,C)-LC in multiple sclerosis.
Journal of biological response modifiers 1985;4(5):544-8.
1985: Bever C T; Whitaker J N
Proteinases in inflammatory demyelinating disease.
Springer seminars in immunopathology 1985;8(3):235-50.
1985: Bever C T; McFarlin D E; Levy H B
A comparison of interferon responses to poly ICLC in males and females.
Journal of interferon research 1985;5(3):423-8.
1984: Eldridge R; Anayiotos C P; Schlesinger S; Cowen D; Bever C; Patronas N; McFarland H
Hereditary adult-onset leukodystrophy simulating chronic progressive multiple sclerosis.
The New England journal of medicine 1984;311(15):948-53.
1984: Bever C T; Dretchen K L; Blake G J; Chang H W; Penn A S; Asofsky R
Augmented anti-acetylcholine receptor response following long-term penicillamine administration.
Annals of neurology 1984;16(1):9-13.
1983: Bever C T; Aquino A V; Penn A S; Lovelace R E; Rowland L P
Prognosis of ocular myasthenia.
Annals of neurology 1983;14(5):516-9.
1983: Miller J R; Burke A M; Bever C T
Occurrence of oligoclonal bands in multiple sclerosis and other CNS diseases.
Annals of neurology 1983;13(1):53-8.
1982: Bever C T; Chang H W; Penn A S; Jaffe I A; Bock E
Penicillamine-induced myasthenia gravis: effects of penicillamine on acetylcholine receptor.
Neurology 1982;32(10):1077-82.

Sign-in to see more